Honda Motor (HMC) Announces Record Production in China for July 2016
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Honda Motor Co., Ltd. announced a summary of automobile production, Japanese domestic sales, and export results for the month of July 2016.Production in Japan for the month of July 2016 experienced a year-on-year increase for the third consecutive month (since May 2016).
Production in regions outside of Japan experienced a year-on-year decrease for the first time in 17 months (since February 2015). This includes record high production for the month of July in Asia and all-time record production in China.Worldwide production experienced a year-on-year decrease for the first time in 14 months (since May 2015).
Total domestic automobile sales in the Japanese market for the month of July 2016 experienced a year-on-year decrease for the second consecutive month (since June 2016).New vehicle registrations experienced a year-on-year decrease for the second consecutive month (since June 2016).
Sales of mini-vehicles experienced a year-on-year decrease for the second consecutive month (since June 2016).
Vehicle registrations - excluding mini-vehicles: Fit was the industry's fifth best-selling car among new vehicle registrations for the month of July 2016 with sales of 9,592 units. VEZEL was the industry's 10th best-selling car with sales of 6,295 units.Mini vehicles - under 660ccN-BOX was the industry's top-selling car in the mini-vehicle category for the month of July 2016 with sales of 13,024 units.
N-WGN was the industry's eighth best-selling car with sales of 6,155 units.Total exports from Japan in July 2016 experienced a year-on-year increase for the 13th consecutive month (since July 2015).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XL Group (XL) Announces Senior Management Changes Related to Realigned P&C Operating Model
- Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M
- Rexahn Pharma (RNN) Announces Receipt of U.S. Patent Related to RX-21101
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!